UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.85 +0.37 (+0.47%) GOLD FUTURES
2,322.50 -8.70 (-0.37%) DOW
38,908.29 +56.02 (+0.14%) Bitcoin GBP
50,862.71 +242.63 (+0.48%)
G1 Therapeutics, Inc. (GTHX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:22PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 223.24M |
| Enterprise value | 205.14M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.64 |
| Price/book (mrq) | 8.05 |
| Enterprise value/revenue | 2.44 |
| Enterprise value/EBITDA | -11.37 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.70 |
| 52-week change 3 | 44.75% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 5.0000 |
| 52-week low 3 | 1.0800 |
| 50-day moving average 3 | 3.9404 |
| 200-day moving average 3 | 2.6674 |
Share statistics
| Avg vol (3-month) 3 | 1.16M |
| Avg vol (10-day) 3 | 570.89k |
| Shares outstanding 5 | 52.28M |
| Implied shares outstanding 6 | 52.28M |
| Float 8 | 43.93M |
| % held by insiders 1 | 11.66% |
| % held by institutions 1 | 30.07% |
| Shares short (15 Apr 2024) 4 | 2.42M |
| Short ratio (15 Apr 2024) 4 | 2.73 |
| Short % of float (15 Apr 2024) 4 | 4.67% |
| Short % of shares outstanding (15 Apr 2024) 4 | 4.63% |
| Shares short (prior month 15 Mar 2024) 4 | 2.69M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -36.40% |
| Operating margin (ttm) | -62.50% |
Management effectiveness
| Return on assets (ttm) | -10.81% |
| Return on equity (ttm) | -84.13% |
Income statement
| Revenue (ttm) | 84.04M |
| Revenue per share (ttm) | 1.62 |
| Quarterly revenue growth (yoy) | 11.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -22.33M |
| Net income avi to common (ttm) | -30.59M |
| Diluted EPS (ttm) | -0.6000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 65.19M |
| Total cash per share (mrq) | 1.25 |
| Total debt (mrq) | 47.09M |
| Total debt/equity (mrq) | 169.76% |
| Current ratio (mrq) | 2.94 |
| Book value per share (mrq) | 0.53 |
Cash flow statement
| Operating cash flow (ttm) | -18.18M |
| Levered free cash flow (ttm) | -4.94M |
© 2024 Yahoo. All rights reserved.